S100B and brain injury: Following some neurological insults, alarmin levels may even be utilized as clinical biomarkers; for instance, plasma levels of HMGB1 and S100B have been correlated with poor outcomes in patients with aneurysmal subarachnoid hemorrhage and traumatic brain injury [161,162,163,164].